After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
NVS belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. At the end of the last regular session, the stock closed at $94.36 and fluctuated between $94.50 as its day high and $93.15 as its day low. The current market capitalization of Novartis AG ADR is $184.61B. A total of 2.34 million shares were traded on the day, compared to an average of 1.49M shares.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Novartis AG ADR pays an annual dividend of $3.74, resulting in a dividend yield of 3.96%, and it has a price to earnings (P/E) ratio of 13.21. NVS’s most recent ex-dividend date was 3/7/2024 when it declared a $3.7772 quarterly dividend that was paid in cash on 3/7/2024. Previously, the company paid the dividend on 3/20/2023 with an ex-dividend date of 3/9/2023. The NVS stock dividend was $3.4694 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NVS has a high of $108.78 and a low of $88.86.
As of this writing, NVS has an earnings estimate of $NVDS per share for the current quarter. EPS was calculated based on a consensus of GraniteShares 1.5x Short NVDA D estimates, with a high estimate of $Novo Nordisk A/S per share and a lower estimate of $CVS Health Corporation.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NVS’s latest balance sheet shows that the firm has $28.11B in Cash & Short Term Investments as of fiscal 2021. There were $31.02B in debt and $30.21B in liabilities at the time. Its Book Value Per Share was $22.83, while its Total Shareholder’s Equity was $67.82B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVS is Buy with a score of 3.60.
